Skip to main content
GutCited

차전자피 관련 만성 변비

A 근거 여러 대규모 임상 시험이 일관되게 유의미한 효과를 보여줍니다.

여러 메타분석에서 차전자피가 배변 횟수(평균 주당 +2.4회)와 대변 무게를 유의하게 증가시키는 것으로 확인되었습니다. 위약 대비 우수하며 변비 완화의 치료필요수(NNT)는 3입니다. AGA 및 ACG 지침에서 권장됩니다.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dpsyllium\u002Dhusk\u0026condition\u003Dconstipation'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

결론

여러 메타분석에서 차전자피가 배변 횟수(평균 주당 +2.4회)와 대변 무게를 유의하게 증가시키는 것으로 확인되었습니다. 위약 대비 우수하며 변비 완화의 치료필요수(NNT)는 3입니다. AGA 및 ACG 지침에서 권장됩니다.

Key Study Findings

Review
The role of dietary fiber in the gastrointestinal tract: when, how and why?
Dose: None vs: None Outcome: None 효과: None None

대상 집단: Review of dietary fiber role in GI tract

Review
Dietary management of chronic constipation: a review of evidence-based strategies and clinical guidelines.
Dose: None vs: None Outcome: None 효과: None None

대상 집단: Review of dietary management of chronic constipation

Review
The role and therapeutic effectiveness of Plantago ovata husk (psyllium husk) in the prevention and …
Dose: None vs: None Outcome: None 효과: None None

대상 집단: Review of psyllium husk for constipation and diarrhea

Meta-Analysis n=410
Conservative, physical and surgical interventions for managing faecal incontinence and constipation in adults with central …
Dose: None vs: Placebo Outcome: Constipation symptoms 효과: SMD -0.62, 95% CI -1.10 to -0.14 None

대상 집단: Alzheimer's disease patients

Randomized Controlled Trial Double-blind
The effect of fiber supplementation with agave fructans or psyllium plantago in symptoms of constipation …
Dose: None vs: None Outcome: Constipation symptoms 효과: None p > 0.05

대상 집단: Constipation patients

Meta-Analysis
Systematic review and meta-analysis: Foods, drinks and diets and their effect on chronic constipation in …
Dose: Various foods, drinks, diets vs: Control diet or placebo Outcome: Stool output, transit time, symptoms, QoL 효과: None None

대상 집단: Adults with chronic constipation

Key Statistics

18

연구

1400

참여자

↑

Positive

A

등급

Referenced Papers

The Medical letter … 2025
Current opinion in … 2024 2 인용
Critical reviews in … 2022 99 인용
Journal of neurogastroenterology … 2021 37 인용
Complementary therapies in … 2021 30 인용
The Medical letter … 2020
International journal of … 2016 69 인용
Revista espanola de … 2016 27 인용
American family physician 2015
Alimentary pharmacology & … 2014 59 인용
The American journal … 2013 421 인용
Journal of clinical … 2011 30 인용
Alimentary pharmacology & … 2011 3 인용
International journal of … 2007 375 인용
Journal of the … 2007 84 인용
Current treatment options … 2006 24 인용
Acta chirurgica Iugoslavica 2006
Der Internist 2005 5 인용
Clinical evidence 2004
Alternative medicine review … 2002 6 인용
Diseases of the … 2001 199 인용
Health technology assessment … 1997 128 인용
Allergy proceedings : … 1990 12 인용
Gastroenterology nursing : … 1989 3 인용
Biomedicine & pharmacotherapy … 1986 4 인용
JAMA 1964

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:
5-10 g/day (with adequate water)
ibssupport:
5-10 g/day (start low, titrate up over 1-2 weeks)
constipation:
10-20 g/day in divided doses with at least 240 mL water per dose

상한량: Well-tolerated up to 30 g/day with adequate fluid intake

연구에서 사용된 용량

용량 기간 효과 N
None -- Mixed --
None -- Mixed --
None -- Positive --
None -- Mixed 410
None -- Negative --
Various foods, drinks, diets -- Positive --
None -- Positive --
None 1 weeks Neutral --

권장 복용 시간: With meals and a full glass of water (240 mL minimum); space 1-2 hours from medications

Safety & Side Effects

보고된 부작용

  • ⚠ Gas and bloating (common initially; start with low dose and titrate up)
  • ⚠ Esophageal/bowel obstruction if taken without adequate water (CRITICAL: always take with full glass of water)
  • ⚠ Abdominal cramping at high initial doses
  • ⚠ May reduce appetite (feeling of fullness)

알려진 상호작용

  • ● May reduce absorption of medications if taken simultaneously (space 1-2 hours)
  • ● Lithium (reduced absorption)
  • ● Carbamazepine (reduced absorption)
  • ● Diabetes medications (may enhance blood sugar lowering; monitor glucose)

일일 최대 섭취 허용량: Well-tolerated up to 30 g/day with adequate fluid intake

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does 차전자피 help with 만성 변비?
Based on 18 studies with 1,400 participants, there is strong evidence from multiple clinical trials that 차전자피 may support 만성 변비 management. Our evidence grade is A (Strong Evidence).
How much 차전자피 should I take for 만성 변비?
Studies have used various dosages. A commonly studied range is 5-10 g/day (with adequate water). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of 차전자피?
Reported side effects may include Gas and bloating (common initially; start with low dose and titrate up), Esophageal/bowel obstruction if taken without adequate water (CRITICAL: always take with full glass of water), Abdominal cramping at high initial doses, May reduce appetite (feeling of fullness). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for 차전자피 and 만성 변비?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 18 peer-reviewed studies with 1,400 total participants. The overall direction of effect is positive.

차전자피 다른 건강 상태에 대한 근거

References

  1. [1] Eirini Dimidi. Proc Nutr Soc. 2025. Dietary management of chronic constipation: a review of evidence-based strategies and clinical guidelines. doi:10.1017/S0029665125100694 PubMed
  2. [2] Justyna Przybyszewska et al.. Prz Gastroenterol. 2025. The role and therapeutic effectiveness of Plantago ovata husk (psyllium husk) in the prevention and non-pharmacological treatment of gastrointestinal diseases. … doi:10.5114/pg.2024.141832 PubMed
  3. [3] Christian von Muhlenbrock et al.. Best Pract Res Clin Gastroenterol. 2025. The role of dietary fiber in the gastrointestinal tract: when, how and why? doi:10.1016/j.bpg.2025.102080 PubMed
  4. [4] . Med Lett Drugs Ther. 2025. Comparison chart: Some drugs for irritable bowel syndrome with constipation (IBS-C). doi:10.58347/tml.2025.1721e PubMed
  5. [5] . Med Lett Drugs Ther. 2025. Drugs for irritable bowel syndrome. doi:10.58347/tml.2025.1721a PubMed
  6. [6] Lvwan Xu et al.. Food Funct. 2024. Synergistic effects of Ligilactobacillus salivarius Li01 and psyllium husk prevent mice from developing loperamide-induced constipation. doi:10.1039/d4fo04444d PubMed
  7. [7] Emeline Keller et al.. J Feline Med Surg. 2024. Psyllium husk powder increases defecation frequency and faecal score, bulk and moisture in healthy cats. doi:10.1177/1098612X241234151 PubMed
  8. [8] Sandra Utz et al.. Z Gastroenterol. 2024. [Phytotherapeutic recommendations in medical guidelines for the treatment of gastroenterological diseases - a systematic review]. doi:10.1055/a-2279-5045 PubMed
  9. [9] Claire L Todd et al.. Cochrane Database Syst Rev. 2024. Conservative, physical and surgical interventions for managing faecal incontinence and constipation in adults with central neurological diseases. doi:10.1002/14651858.CD002115.pub6 PubMed
  10. [10] Enrique Coss-Adame et al.. Neurogastroenterol Motil. 2024. The effect of fiber supplementation with agave fructans or psyllium plantago in symptoms of constipation and its relation with whole … doi:10.1111/nmo.14908 PubMed
  11. [11] Daniel Staursky et al.. Curr Opin Gastroenterol. 2024. Step on the accelerator: modern treatment of constipation. doi:10.1097/MOG.0000000000000982 PubMed
  12. [12] Alice Van Der Schoot et al.. Aliment Pharmacol Ther. 2024. Systematic review and meta-analysis: Foods, drinks and diets and their effect on chronic constipation in adults. doi:10.1111/apt.17782 PubMed
  13. [13] Hao Lai et al.. Gut Microbes. 2023. Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial. doi:10.1080/19490976.2023.2197837 PubMed
  14. [14] Silvia Salvatore et al.. Nutrients. 2023. Dietary Fibers in Healthy Children and in Pediatric Gastrointestinal Disorders: A Practical Guide. doi:10.3390/nu15092208 PubMed
  15. [15] Richard Gearry et al.. Am J Gastroenterol. 2023. Consumption of 2 Green Kiwifruits Daily Improves Constipation and Abdominal Comfort-Results of an International Multicenter Randomized Controlled Trial. doi:10.14309/ajg.0000000000002124 PubMed
  16. [16] Blake J Purtle et al.. Ann Intern Med. 2023. In persons with constipation or IBS-C, kiwifruit vs. psyllium increased spontaneous bowel movements. doi:10.7326/J23-0022 PubMed
  17. [17] Mayara Belorio et al.. Crit Rev Food Sci Nutr. 2022. Psyllium: a useful functional ingredient in food systems. doi:10.1080/10408398.2020.1822276 PubMed
  18. [18] Alice van der Schoot et al.. Am J Clin Nutr. 2022. The Effect of Fiber Supplementation on Chronic Constipation in Adults: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials. doi:10.1093/ajcn/nqac184 PubMed
  19. [19] Waseem Khalid et al.. Food Sci Nutr. 2022. Fiber-enriched botanicals: A therapeutic tool against certain metabolic ailments. doi:10.1002/fsn3.2920 PubMed
  20. [20] Mohamed Eltorki et al.. Can J Gastroenterol Hepatol. 2022. Kiwifruit and Kiwifruit Extracts for Treatment of Constipation: A Systematic Review and Meta-Analysis. doi:10.1155/2022/7596920 PubMed
  21. [21] Satish S C Rao et al.. Am J Gastroenterol. 2021. Efficacy and Safety of Over-the-Counter Therapies for Chronic Constipation: An Updated Systematic Review. doi:10.14309/ajg.0000000000001222 PubMed
  22. [22] Samuel W Chey et al.. Am J Gastroenterol. 2021. Exploratory Comparative Effectiveness Trial of Green Kiwifruit, Psyllium, or Prunes in US Patients With Chronic Constipation. doi:10.14309/ajg.0000000000001149 PubMed
  23. [23] Seung Joo Kang et al.. J Neurogastroenterol Motil. 2021. Medical Management of Constipation in Elderly Patients: Systematic Review. doi:10.5056/jnm20210 PubMed
  24. [24] Neha R Santucci et al.. Complement Ther Med. 2021. Non-pharmacologic approach to pediatric constipation. doi:10.1016/j.ctim.2021.102711 PubMed
  25. [25] Teodora Surdea-Blaga et al.. Curr Opin Gastroenterol. 2021. Dietary interventions and irritable bowel syndrome - what really works? doi:10.1097/MOG.0000000000000706 PubMed
  26. [26] Johnson W McRorie et al.. J Am Assoc Nurse Pract. 2020. Laxative effects of wheat bran and psyllium: Resolving enduring misconceptions about fiber in treatment guidelines for chronic idiopathic constipation. doi:10.1097/JXX.0000000000000346 PubMed
  27. [27] . Med Lett Drugs Ther. 2020. Drugs for Irritable Bowel Syndrome. PubMed
  28. [28] Paul Moayyedi et al.. J Can Assoc Gastroenterol. 2019. Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable Bowel Syndrome (IBS). doi:10.1093/jcag/gwy071 PubMed
  29. [29] Jonna Jalanka et al.. Int J Mol Sci. 2019. The Effect of Psyllium Husk on Intestinal Microbiota in Constipated Patients and Healthy Controls. doi:10.3390/ijms20020433 PubMed
  30. [30] Noureddin Soltanian et al.. Clin Nutr ESPEN. 2019. Effect of flaxseed or psyllium vs. placebo on management of constipation, weight, glycemia, and lipids: A randomized trial in constipated … doi:10.1016/j.clnesp.2018.11.002 PubMed
  31. [31] Liang Dai et al.. World J Clin Cases. 2019. Irritable bowel syndrome and functional constipation management with integrative medicine: A systematic review. doi:10.12998/wjcc.v7.i21.3486 PubMed
  32. [32] E R Ceresola et al.. Eur Rev Med Pharmacol Sci. 2018. Targeting patients' microbiota with probiotics and natural fibers in adults and children with constipation. doi:10.26355/eurrev_201810_16177 PubMed
  33. [33] S Vande Velde et al.. Acta Gastroenterol Belg. 2018. Constipation and fecal incontinence in children with cerebral palsy. Overview of literature and flowchart for a stepwise approach. PubMed
  34. [34] Wendy J Dahl et al.. Can J Diet Pract Res. 2018. Is Fibre an Effective Strategy to Improve Laxation in Long-Term Care Residents? doi:10.3148/cjdpr-2017-028 PubMed
  35. [35] Johnson W McRorie et al.. J Acad Nutr Diet. 2017. Understanding the Physics of Functional Fibers in the Gastrointestinal Tract: An Evidence-Based Approach to Resolving Enduring Misconceptions about Insoluble and … doi:10.1016/j.jand.2016.09.021 PubMed
  36. [36] Diego Currò et al.. Br J Pharmacol. 2017. Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders. doi:10.1111/bph.13632 PubMed
  37. [37] V G M Prasad et al.. Indian J Gastroenterol. 2017. Management of chronic constipation in patients with diabetes mellitus. doi:10.1007/s12664-016-0724-2 PubMed
  38. [38] Monica R P Rao et al.. Int J Biol Macromol. 2016. Phosphorylation of psyllium seed polysaccharide and its characterization. doi:10.1016/j.ijbiomac.2015.12.043 PubMed
  39. [39] Johnson W McRorie et al.. Dig Dis Sci. 2016. Fermented Fiber Supplements Are No Better Than Placebo for a Laxative Effect. doi:10.1007/s10620-016-4304-1 PubMed
  40. [40] Miguel Mínguez et al.. Rev Esp Enferm Dig. 2016. Use of polyethylene glycol in functional constipation and fecal impaction. doi:10.17235/reed.2016.4571/2016 PubMed
  41. [41] Anne Mounsey et al.. Am Fam Physician. 2015. Management of Constipation in Older Adults. PubMed
  42. [42] E Lever et al.. Aliment Pharmacol Ther. 2014. Systematic review: the effect of prunes on gastrointestinal function. doi:10.1111/apt.12913 PubMed
  43. [43] Si-Le Chen et al.. Medicine (Baltimore). 2014. Efficacy and complications of polyethylene glycols for treatment of constipation in children: a meta-analysis. doi:10.1097/MD.0000000000000065 PubMed
  44. [44] Shanti Eswaran et al.. Am J Gastroenterol. 2013. Fiber and functional gastrointestinal disorders. doi:10.1038/ajg.2013.63 PubMed
  45. [45] K E Trinkley et al.. J Clin Pharm Ther. 2011. Treatment of irritable bowel syndrome. doi:10.1111/j.1365-2710.2010.01177.x PubMed
  46. [46] E P Halmos et al.. Aliment Pharmacol Ther. 2011. Dried plums, constipation and the irritable bowel syndrome. doi:10.1111/j.1365-2036.2011.04719.x PubMed
  47. [47] . Prescrire Int. 2009. Irritable bowel syndrome: a mild disorder; purely symptomatic treatment. PubMed
  48. [48] Baljit Singh. Int J Pharm. 2007. Psyllium as therapeutic and drug delivery agent. doi:10.1016/j.ijpharm.2007.01.028 PubMed
  49. [49] Syed H Tariq. J Am Med Dir Assoc. 2007. Constipation in long-term care. doi:10.1016/j.jamda.2007.02.009 PubMed
  50. [50] Howard Y Chang et al.. Curr Treat Options Gastroenterol. 2006. Current gut-directed therapies for irritable bowel syndrome. doi:10.1007/s11938-006-0013-8 PubMed
  51. [51] M Ceranić et al.. Acta Chir Iugosl. 2006. [Plantago ovata]. doi:10.2298/aci0601009c PubMed
  52. [52] H Krammer et al.. Internist (Berl). 2005. [Therapeutic options of chronic constipation]. doi:10.1007/s00108-005-1509-3 PubMed
  53. [53] C J Bijkerk et al.. Aliment Pharmacol Ther. 2004. Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome. doi:10.1111/j.0269-2813.2004.01862.x PubMed
  54. [54] Bazian Ltd. Clin Evid. 2004. Constipation in adults. PubMed
  55. [55] . Altern Med Rev. 2002. Plantago ovata. (Psyllium). PubMed
  56. [56] J H Xing et al.. Dis Colon Rectum. 2001. Adverse effects of laxatives. doi:10.1007/BF02234645 PubMed
  57. [57] W Ashraf et al.. Mov Disord. 1997. Constipation in Parkinson's disease: objective assessment and response to psyllium. doi:10.1002/mds.870120617 PubMed
  58. [58] M Petticrew et al.. Health Technol Assess. 1997. Systematic review of the effectiveness of laxatives in the elderly. PubMed
  59. [59] G L Sussman et al.. Allergy Proc. 1990. Psyllium anaphylaxis. doi:10.2500/108854190778879828 PubMed
  60. [60] M L Swartz. Gastroenterol Nurs. 1989. Citrucel (methylcellulose/bulk-forming laxative). doi:10.1097/00001610-198907000-00013 PubMed
  61. [61] A Prior et al.. Gut. 1987. Double blind study of ispaghula in irritable bowel syndrome. doi:10.1136/gut.28.11.1510 PubMed
  62. [62] A Prior et al.. Biomed Pharmacother. 1986. Management of irritable bowel syndrome. PubMed
  63. [63] A P KLOTZ. JAMA. 1964. IRRITABLE COLON. PubMed

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.